SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-20-013682
Filing Date
2020-09-16
Accepted
2020-09-16 21:32:20
Documents
4
Period of Report
2020-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_160030632507522.html 3  
1 FORM 3 wf-form3_160030632507522.xml 3 1779
2 POWER OF ATTORNEY RS rockwell-poaxskibstedxex.htm EX-24 962
3 POA P1 rockwell-poaxskibstedxex001.jpg GRAPHIC 224630
4 POA P2 rockwell-poaxskibstedxex002.jpg GRAPHIC 60997
  Complete submission text file 0001628280-20-013682.txt   398093
Mailing Address 411 HACKENSACK AVE., SUITE 501 HACKENSACK NJ 07601
Business Address 411 HACKENSACK AVE., SUITE 501 HACKENSACK NJ 07601 2489609009
ROCKWELL MEDICAL, INC. (Issuer) CIK: 0001041024 (see all company filings)

IRS No.: 383317208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 TRANQUILITY PLACE LADERA RANCH CA 92694
Business Address
SKIBSTED RUSSELL (Reporting) CIK: 0001308105 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23661 | Film No.: 201180002